A real world evidence study from Germany on the safety and efficacy of tapentadol and typical oral long-acting opioid analgesics in chronic low back pain patients (1o2toTAPoLAO)

First published 29/11/2020

Last updated 23/04/2024

EU PAS number:

EUPAS38332

Study

Finalised

Download as PDF

Documents

Study protocol

No information provided.

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

A real world evidence study from Germany on the safety and efficacy of tapentadol and typical oral long-acting opioid analgesics in chronic low back pain patients (1o2toTAPoLAO)

Secondary tabs

Share this page